Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Boris Itkin"'
Autor:
Boris Itkin, Samanta Straminsky, Hernán Cáceres, Mariana Onassis, Agustín Emilio García, Laura Avanzi, Lucia Kaminszczik, Richard Serna Sejas, Mara Rapaccioli, Gustavo Billordo, Damián Lavaccara, Julián Lanzavecchia, Luz Gibbons, Eugenia Settecase, Ariel Bardach
Publikováno v:
Revista Peruana de Medicina Experimental y Salud Pública, Pp 161-9 (2023)
Objectives. To compare the mortality of unvaccinated oncology patients who received chemotherapy or immunotherapy during the pandemic with those treated before the pandemic. Materials and methods. We conducted a cohort study in four tertiary hospital
Externí odkaz:
https://doaj.org/article/cc8d1f9c7dfb47e8a95df4d74a0d2cdd
Autor:
Boris Itkin, Agustin Garcia, Samanta Straminsky, Eduardo Daniel Adelchanow, Matias Pereyra, Gabriela Acosta Haab, Ariel Bardach
Publikováno v:
PLoS ONE, Vol 16, Iss 9, p e0257976 (2021)
The reported rates of HER2 positivity in cervical cancer (CC) range from 0% to 87%. The importance of HER2 as an actionable target in CC would depend on HER2 positivity prevalence. Our aim was to provide precise estimates of HER2 overexpression and a
Externí odkaz:
https://doaj.org/article/ab8ebf92343e4ebdb6a4668c08a9319c
Autor:
Boris Itkin, Alastair Breen, Lyudmila Turyanska, Eduardo Omar Sandes, Tracey D. Bradshaw, Andrea Irene Loaiza-Perez
Publikováno v:
International Journal of Molecular Sciences, Vol 21, Iss 10, p 3551 (2020)
Kidney cancer rapidly acquires resistance to antiangiogenic agents, such as sunitinib, developing an aggressive migratory phenotype (facilitated by c-Metsignal transduction). The Aryl hydrocarbon receptor (AhR) has recently been postulated as a molec
Externí odkaz:
https://doaj.org/article/aee15a1d54df437a8208ff606ca752c7
Publikováno v:
Oxford Medical Case Reports. 2023
Clostridium cadaveris (C. cadaveris), a strict anaerobic gram-positive rod, is rarely reported in clinical specimens. Since its detection in 1899, it has always been linked to the decay of dead bodies. C. cadaveris is considered non-pathogenic to hum
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::28b3f3fc8322813fa2b45f2834d589f9
https://doi.org/10.1093/omcr/omac146
https://doi.org/10.1093/omcr/omac146
Autor:
Boris, Itkin, Rodrigo, Segovia, Samanta, Straminsky, Lucia, Kamincsczik, Laura, Avanzi, Bruno, Bustos, Ariel, Bardach
Publikováno v:
Revista Argentina de Salud Pública, Vol 12, Pp 1-7 (2020)
Los retrasos en el inicio de los tratamientos oncológicos pueden afectar su eficacia. El objetivo del estudio fue caracterizar las demoras en la entrega de los tratamientos onco-específicos no quirúrgicos y el grado de conformidad con el trámite
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doajarticles::684a41c89ad87114c4cc6a8168377e54
http://rasp.msal.gov.ar/rasp/articulos/vol12/AO-itkin.pdf
http://rasp.msal.gov.ar/rasp/articulos/vol12/AO-itkin.pdf
Autor:
Boris Itkin, Agustin Garcia, Samanta Straminsky, Eduardo Daniel Adelchanow, Matias Pereyra, Gabriela Acosta Haab, Ariel Bardach
BackgroundThe reported rates of HER2 positivity in uterine cervical cancer (CC) range from 0–87%. The organization of clinical studies of HER2 targeting agents in CC requires a better knowledge of HER2 positivity prevalence. We aimed to provide pre
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::28fe7f7b4eb0fbaafc6dcb2ab7bd4c8d
https://doi.org/10.21203/rs.3.rs-288200/v1
https://doi.org/10.21203/rs.3.rs-288200/v1
Autor:
Matias Pereyra, Samanta Straminsky, Boris Itkin, Ariel Bardach, Gabriela Acosta Haab, Eduardo Daniel Adelchanow, Agustin Garcia
Publikováno v:
PLoS ONE, Vol 16, Iss 9, p e0257976 (2021)
PLoS ONE
PLoS ONE
The reported rates of HER2 positivity in cervical cancer (CC) range from 0% to 87%. The importance of HER2 as an actionable target in CC would depend on HER2 positivity prevalence. Our aim was to provide precise estimates of HER2 overexpression and a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1ede4c96096b5d7d26a5372893276fa1
https://doaj.org/article/ab8ebf92343e4ebdb6a4668c08a9319c
https://doaj.org/article/ab8ebf92343e4ebdb6a4668c08a9319c
Autor:
Eduardo Omar Sandes, Andrea I. Loaiza-Pérez, Lyudmila Turyanska, Boris Itkin, Alastair F. Breen, Tracey D. Bradshaw
Publikováno v:
CONICET Digital (CONICET)
Consejo Nacional de Investigaciones Científicas y Técnicas
instacron:CONICET
International Journal of Molecular Sciences, Vol 21, Iss 3551, p 3551 (2020)
International Journal of Molecular Sciences
Consejo Nacional de Investigaciones Científicas y Técnicas
instacron:CONICET
International Journal of Molecular Sciences, Vol 21, Iss 3551, p 3551 (2020)
International Journal of Molecular Sciences
Kidney cancer rapidly acquires resistance to antiangiogenic agents, such as sunitinib, developing an aggressive migratory phenotype (facilitated by c-Metsignal transduction). The Aryl hydrocarbon receptor (AhR) has recently been postulated as a molec
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::69e49b79d9f8cf56df4c49795e4afd81
Autor:
G. Acosta Haab, Samanta Straminsky, A. Garcia, Eduardo Daniel Adelchanow, Ariel Bardach, Boris Itkin, M. Pereyra
Publikováno v:
Annals of Oncology. 32:S767
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b7063817a732f4ee75ad0c9ea990f601
https://doi.org/10.1016/j.annonc.2021.08.1256
https://doi.org/10.1016/j.annonc.2021.08.1256
Autor:
Boris Itkin, Laura Avanzi, Lucía Kaminszczik, Gabriela De Ronato, Samanta Straminsky, Jonathan Vargas, Hugo Terranova Intriago, Diana González Álvarez, Agustina Dupont, Bruno Bustos, Daniel Lewi, Ariel Bardach
Publikováno v:
Oncología Clínica. 24
Si bien se estudió ampliamente la discordancia de los receptores hormonales en la evolución del cáncer de mama, casi siempre se trató como una variable dicotómica, sin tener en cuenta sus valores absolutos. El grado, la dirección y la imp
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d928843e818e2a982afb0e0fe7b96e96
https://doi.org/10.56969/oc.v24i2.39
https://doi.org/10.56969/oc.v24i2.39